- 期刊
- OpenAccess
Bioinformatic Analysis of Circadian Expression of Oncogenes and Tumor Suppressor Genes
摘要
BACKGROUND: Circadian rhythms are physiological and behavioral cycles with a period of approximately 24 hours that control various functions including gene expression. Circadian disruption is associated with a variety of diseases, especially cancer. Although some of the oncogenes and tumor suppressor genes (TSGs) are known as clock-controlled genes (CCGs), the analysis and annotation of circadian expression of most human oncogenes and TSGs are still lacking. This study aims to investigate the circadian expression of a list of human oncogenes and TSGs. METHODS: A bioinformatic analysis was conducted on a gene library comprising 120 genes to investigate the circadian expression of human oncogenes and TSGs. To achieve this purpose, the genotranscriptomic data were retrieved from COSMIC and analyzed by R statistical software. Furthermore, the acquired data were analyzed at the transcriptomic and proteomic levels using several publicly available databases. Also, the significance of all analyses was confirmed statistically. RESULTS: Altogether, our results indicated that 7 human oncogenes/TSGs may be expressed and function in a circadian manner. These oncogenes/TSGs showed a circadian expression pattern at CircaDB database and associated with at least one of the circadian genes/ CCGs based on both genotranscriptomic and correlation analyses. CONCLUSIONS: Although 4 of 7 finally outputted genes have been previously reported to be clock controlled, heretofore there is no report about the circadian expression of 3 other genes. Considering the importance of oncogenes/TSGs in the initiation and progression of cancer, further studies are suggested for the identification of exact circadian expression patterns of these 3 human oncogenes/TSGs.
延伸閱讀
- Hicks, C., Koganti, T., Giri, S., Tekere, M., Ramani, R., Amorn, J. S., & Vijayakumar, S. (2014). Integrative Genomic Analysis for the Discovery of Biomarkers in Prostate Cancer. Biomarker Insights, 2014(), 39-51. https://doi.org/10.4137/BMI.S13729
- Ganesan, K., Banerjee, S., Gunasekaran, P., Tan, P., & Rayala, S. K. (2010). Integrative Functional Genomics in Cancer Research and Its Clinical Implications. Journal of Cancer Molecules, 5(3), 65-71. https://doi.org/10.29685/JCM.201008.0001
- Li, W. M. (2017). Genomic and transcriptomic analyses of prognostic biomarkers in urothelial carcinoma [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-0907201723163300
- Hsu, C. Y. (2016). Identification of tumor suppressors and EGFR-TKI resistance genes by systemic approaches [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201610471
- Hu, C. Y. (2010). Identification of disease-related genes using bioinformatics analysis [master's thesis, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-2207201017015700